Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Nuvo Research Inc -- Ignore unavailable to you. Want to Upgrade?

To: Mark Bartlett who wrote (8612)	2/1/2002 12:34:48 AM
From: Cal Gary	Read Replies (1) \| Respond to of 14101

Thanks Mark. I'll put you down as not significant, like Di7026. Ron, its just you and me, for significant. I don't know what "C&T" stands for. Hmmm, Copyright and Trademark? Stalemate. PS Welcome to February 2002, of course EST. ------------------ Another opinion snipped from the JnJ Yahoo thread: Re: JNJ pharmaceutical patent expiration by: rea456 01/30/02 09:42 am Msg: 10823 of 10826 I think your numbers are correct. The good news is that JNJ has a number of drugs with high sales and limited patent exposure, the bad news is that they need more drugs in the pipeline (especially late stage). Let's see what Bill Weldon, Christine Poon, etc. can do.